Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06224205 · ClinicalTrials.gov registry record · NA
Digital Detection of Dementia (D Cubed) Studies: D3
A NA study of Alzheimer Disease and Related Dementias (ADRD), sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 3,150
- Enrollment target
- 1
- Study location
NCT06224205: Recruiting NA study of Alzheimer Disease and Related Dementias (ADRD), sponsored by Indiana University.
NCT06224205 is a NA study of Alzheimer Disease and Related Dementias (ADRD) that is actively recruiting participants, run by Indiana University. The registered enrollment target is 3,150 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (124% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06224205, a NA study of Alzheimer Disease and Related Dementias (ADRD), is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,150 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.
Primary Outcome
The primary outcome measure will be any new ADRD case identified (documented in the EHR) within 12 months of the Annual Wellness Visit (index visit).
Conditions Studied
Interventions
- OTHER Passive Digital Marker for screening for ADRD
Study Locations (1)
Florida
- University of Miami School of Medicine - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,150 participants |
| Start Date | 2023-11-08 |
| Est. Completion | 2025-11-08 |
| Phase | NA |
What NCT06224205 shows while recruiting
NCT06224205 is an interventional study that assigns participants to a tested intervention. Its 3,150 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (124% higher).
The record links to 1 condition, with Alzheimer Disease and Related Dementias (ADRD) appearing as the primary indexed condition, and to 1 intervention - of which Passive Digital Marker for screening for ADRD is the first listed.
NCT06224205 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06224205 about?
NCT06224205 is a clinical study titled "Digital Detection of Dementia (D Cubed) Studies: D3". The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.
What is the current status of trial NCT06224205?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,150 participants. The study started on 2023-11-08. Estimated completion is 2025-11-08.
What conditions does trial NCT06224205 study?
This clinical trial studies the following conditions: Alzheimer Disease and Related Dementias (ADRD).
What interventions are being tested in trial NCT06224205?
The interventions under investigation include: Passive Digital Marker for screening for ADRD (OTHER).
Who is sponsoring clinical trial NCT06224205?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06224205 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease and Related Dementias (ADRD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06224205's enrollment target sits among peer trials
3,150 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05051722 · 3,110 participants
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- NCT02043457 · 3,200 participants
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
- NCT04045665 · 3,200 participants · Phase 3
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- NCT05381766 · 3,200 participants · NA
Building Access to Food Through Systems and Solidarity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI